D M Maynard1, H F G Heijnen, W A Gahl, M Gunay-Aygun. 1. Section on Human Biochemical Genetics, Medical Genetics Branch, National Human Genome Research Institute, NIH, Bethesda, MD, USA. maynardd@mail.nih.gov
Abstract
BACKGROUND: Deficiencies in granule-bound substances in platelets cause congenital bleeding disorders known as storage pool deficiencies. For disorders such as gray platelet syndrome (GPS), in which thrombocytopenia, enlarged platelets and a paucity of α-granules are observed, only the clinical and histologic states have been defined. OBJECTIVES: In order to understand the molecular defect in GPS, the α-granule fraction protein composition from a normal individual was compared with that of a GPS patient by mass spectrometry (MS). METHODS: Platelet organelles were separated by sucrose gradient ultracentrifugation. Proteins from sedimented fractions were separated by sodium dodecylsulfate polyacrylamide gel electrophoresis, reduced, alkylated, and digested with trypsin. Peptides were analyzed by liquid chromatography-tandem MS. Mascot was used for peptide/protein identification and to determine peptide false-positive rates. MassSieve was used to generate and compare parsimonious lists of proteins. RESULTS: As compared with control, the normalized peptide hits (NPHs) from soluble, biosynthetic α-granule proteins were markedly decreased or undetected in GPS platelets, whereas the NPHs from soluble, endocytosed α-granule proteins were only moderately affected. The NPHs from membrane-bound α-granule proteins were similar in normal platelets and GPS platelets, although P-selectin and Glut3 were slightly decreased, consistent with immunoelectron microscopy findings in resting platelets. We also identified proteins not previously known to be decreased in GPS, including latent transforming growth factor-β-binding protein 1(LTBP1), a component of the transforming growth factor-β (TGF-β) complex. CONCLUSIONS: Our results support the existence of 'ghost granules' in GPS, point to the basic defect in GPS as failure to incorporate endogenously synthesized megakaryocytic proteins into α-granules, and identify specific new proteins as α-granule inhabitants.
BACKGROUND: Deficiencies in granule-bound substances in platelets cause congenital bleeding disorders known as storage pool deficiencies. For disorders such as gray platelet syndrome (GPS), in which thrombocytopenia, enlarged platelets and a paucity of α-granules are observed, only the clinical and histologic states have been defined. OBJECTIVES: In order to understand the molecular defect in GPS, the α-granule fraction protein composition from a normal individual was compared with that of a GPSpatient by mass spectrometry (MS). METHODS: Platelet organelles were separated by sucrose gradient ultracentrifugation. Proteins from sedimented fractions were separated by sodium dodecylsulfatepolyacrylamide gel electrophoresis, reduced, alkylated, and digested with trypsin. Peptides were analyzed by liquid chromatography-tandem MS. Mascot was used for peptide/protein identification and to determine peptide false-positive rates. MassSieve was used to generate and compare parsimonious lists of proteins. RESULTS: As compared with control, the normalized peptide hits (NPHs) from soluble, biosynthetic α-granule proteins were markedly decreased or undetected in GPS platelets, whereas the NPHs from soluble, endocytosed α-granule proteins were only moderately affected. The NPHs from membrane-bound α-granule proteins were similar in normal platelets and GPS platelets, although P-selectin and Glut3 were slightly decreased, consistent with immunoelectron microscopy findings in resting platelets. We also identified proteins not previously known to be decreased in GPS, including latent transforming growth factor-β-binding protein 1(LTBP1), a component of the transforming growth factor-β (TGF-β) complex. CONCLUSIONS: Our results support the existence of 'ghost granules' in GPS, point to the basic defect in GPS as failure to incorporate endogenously synthesized megakaryocytic proteins into α-granules, and identify specific new proteins as α-granule inhabitants.
Authors: Xiaoyu Yang; Vijay Dondeti; Rebecca Dezube; Dawn M Maynard; Lewis Y Geer; Jonathan Epstein; Xiongfong Chen; Sanford P Markey; Jeffrey A Kowalak Journal: J Proteome Res Date: 2004 Sep-Oct Impact factor: 4.466
Authors: T C Falik-Zaccai; Y Anikster; C E Rivera; M K Horne; L Schliamser; C Phornphutkul; D Attias; T Hyman; J G White; W A Gahl Journal: Mol Genet Metab Date: 2001-11 Impact factor: 4.797
Authors: Valentina A Schmidt; Lesley Scudder; Craig E Devoe; André Bernards; Lisa D Cupit; Wadie F Bahou Journal: Blood Date: 2002-12-19 Impact factor: 22.113
Authors: Meral Gunay-Aygun; Yifat Zivony-Elboum; Fatma Gumruk; Dan Geiger; Mualla Cetin; Morad Khayat; Robert Kleta; Nehama Kfir; Yair Anikster; Judith Chezar; Mauricio Arcos-Burgos; Adel Shalata; Horia Stanescu; Joseph Manaster; Mutlu Arat; Hailey Edwards; Andrew S Freiberg; P Suzanne Hart; Lauren C Riney; Katherine Patzel; Pranoot Tanpaiboon; Tom Markello; Marjan Huizing; Irina Maric; McDonald Horne; Beate E Kehrel; Kerstin Jurk; Nancy F Hansen; Praveen F Cherukuri; Marypat Jones; Pedro Cruz; Jim C Mullikin; Alan Nurden; James G White; William A Gahl; Tzippora Falik-Zaccai Journal: Blood Date: 2010-08-13 Impact factor: 22.113
Authors: Cathelijn E M Aarts; Kate Downes; Arie J Hoogendijk; Evelien G G Sprenkeler; Roel P Gazendam; Rémi Favier; Marie Favier; Anton T J Tool; John L van Hamme; Myrto A Kostadima; Kate Waller; Barbara Zieger; Maaike G J M van Bergen; Saskia M C Langemeijer; Bert A van der Reijden; Hans Janssen; Timo K van den Berg; Robin van Bruggen; Alexander B Meijer; Willem H Ouwehand; Taco W Kuijpers Journal: Blood Adv Date: 2021-01-26
Authors: Pani A Apostolidis; Stephan Lindsey; William M Miller; Eleftherios T Papoutsakis Journal: Physiol Genomics Date: 2012-05-01 Impact factor: 3.107
Authors: Carsten Deppermann; Deya Cherpokova; Paquita Nurden; Jan-Niklas Schulz; Ina Thielmann; Peter Kraft; Timo Vögtle; Christoph Kleinschnitz; Sebastian Dütting; Georg Krohne; Sabine A Eming; Alan T Nurden; Beate Eckes; Guido Stoll; David Stegner; Bernhard Nieswandt Journal: J Clin Invest Date: 2013-07-01 Impact factor: 14.808
Authors: Matthew C Sims; Louisa Mayer; Janine H Collins; Tadbir K Bariana; Karyn Megy; Cecile Lavenu-Bombled; Denis Seyres; Laxmikanth Kollipara; Frances S Burden; Daniel Greene; Dave Lee; Antonio Rodriguez-Romera; Marie-Christine Alessi; William J Astle; Wadie F Bahou; Loredana Bury; Elizabeth Chalmers; Rachael Da Silva; Erica De Candia; Sri V V Deevi; Samantha Farrow; Keith Gomez; Luigi Grassi; Andreas Greinacher; Paolo Gresele; Dan Hart; Marie-Françoise Hurtaud; Anne M Kelly; Ron Kerr; Sandra Le Quellec; Thierry Leblanc; Eva B Leinøe; Rutendo Mapeta; Harriet McKinney; Alan D Michelson; Sara Morais; Diane Nugent; Sofia Papadia; Soo J Park; John Pasi; Gian Marco Podda; Man-Chiu Poon; Rachel Reed; Mallika Sekhar; Hanna Shalev; Suthesh Sivapalaratnam; Orna Steinberg-Shemer; Jonathan C Stephens; Robert C Tait; Ernest Turro; John K M Wu; Barbara Zieger; Taco W Kuijpers; Anthony D Whetton; Albert Sickmann; Kathleen Freson; Kate Downes; Wendy N Erber; Mattia Frontini; Paquita Nurden; Willem H Ouwehand; Remi Favier; Jose A Guerrero Journal: Blood Date: 2020-10-22 Impact factor: 22.113